KWA-0711 clinical trials
Also written KWA-0711.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2014
How each study uses KWA-0711 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- KWA-0711
- 5
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Studies
Open first, then newest update. How each study uses KWA-0711 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC)CompletedPhase 2Kissei Pharmaceutical Co., Ltd.NCT02281630Written as KWA-0711How we know
- Phase II Study of KWA-0711 in Patients With Chronic Constipation (CC)CompletedPhase 2Kissei Pharmaceutical Co., Ltd.NCT02343978Written as KWA-0711How we know
- Study of Absorption, Metabolism and Excretion Following a Single Oral Dose of [14C]KWA-0711 to Healthy Male SubjectsCompletedPhase 1Kissei Pharmaceutical Co., Ltd.NCT02434835Written as [14C]KWA-0711How we know
- A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic ConstipationCompletedPhase 2Kissei Pharmaceutical Co., Ltd.NCT01937663Written as KWA-0711How we know
- A Single-blind, Dose-titration Study of KWA-0711 in Patients With Chronic ConstipationCompletedPhase 2Kissei Pharmaceutical Co., Ltd.NCT01938196Written as KWA-0711How we know
- A Exploratory Study of KWA-0711 in Patients With Chronic Idiopathic Constipation (CIC)CompletedPhase 2Kissei Pharmaceutical Co., Ltd.NCT01600001Written as KWA-0711How we know